Tepotinib safety in MET exon 14 (METex14) skipping NSCLC: Updated results from the VISION trial Meeting Abstract
| Authors: | Morise, M.; Sakai, H.; Veillon, R.; Le, X.; Felip, E.; Garassino, M. C.; Cortot, A. B.; Smit, E.; Park, K.; Griesinger, F.; Britschgi, C.; Wu, Y. L.; Berghoff, K.; Otto, G.; Bruns, R.; Paik, P. |
| Abstract Title: | Tepotinib safety in MET exon 14 (METex14) skipping NSCLC: Updated results from the VISION trial |
| Meeting Title: | 2021 Annual Meeting of the Japanese Society of Medical Oncology (JSMO) |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2021 Feb 18-21 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-07-01 |
| Start Page: | S291 |
| Language: | English |
| ACCESSION: | WOS:000683609100128 |
| DOI: | 10.1016/j.annonc.2021.05.541 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: O13-4 -- Source: Wos |
